Armata Pharmaceuticals ARMP Stock
Armata Pharmaceuticals Price Chart
Armata Pharmaceuticals ARMP Financial and Trading Overview
| Armata Pharmaceuticals stock price | 1.28 USD |
| Previous Close | 1.55 USD |
| Open | 1.43 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 1.4 - 1.58 USD |
| 52 Week Range | 0.83 - 4.92 USD |
| Volume | 9.36K USD |
| Avg. Volume | 8.62K USD |
| Market Cap | 52.05M USD |
| Beta (5Y Monthly) | 0.546848 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.89 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 USD |
ARMP Valuation Measures
| Enterprise Value | 104.27M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.114286 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.270002 |
| Price/Book (mrq) | 2.3188407 |
| Enterprise Value/Revenue | 20.575 |
| Enterprise Value/EBITDA | -2.7 |
Trading Information
Armata Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.546848 |
| 52-Week Change | -60.22% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.92 USD |
| 52 Week Low | 0.83 USD |
| 50-Day Moving Average | 1.47 USD |
| 200-Day Moving Average | 2.4 USD |
ARMP Share Statistics
| Avg. Volume (3 month) | 8.62K USD |
| Avg. Daily Volume (10-Days) | 9.59K USD |
| Shares Outstanding | 36.14M |
| Float | 10.99M |
| Short Ratio | 2.92 |
| % Held by Insiders | 70.07% |
| % Held by Institutions | 3.63% |
| Shares Short | 21.89K |
| Short % of Float | 0.080% |
| Short % of Shares Outstanding | 0.059% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -779.73% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.81% |
| Return on Equity (ttm) | -101.52% |
Income Statement
| Revenue (ttm) | 5.07M USD |
| Revenue Per Share (ttm) | 0.14 USD |
| Quarterly Revenue Growth (yoy) | -35.60% |
| Gross Profit (ttm) | -29509000 USD |
| EBITDA | -38621000 USD |
| Net Income Avi to Common (ttm) | -42633000 USD |
| Diluted EPS (ttm) | -1.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 25.11M USD |
| Total Cash Per Share (mrq) | 0.7 USD |
| Total Debt (mrq) | 77.33M USD |
| Total Debt/Equity (mrq) | 344.51 USD |
| Current Ratio (mrq) | 0.751 |
| Book Value Per Share (mrq) | 0.621 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -46536000 USD |
| Levered Free Cash Flow (ttm) | -34299124 USD |
Profile of Armata Pharmaceuticals
| Country | United States |
| State | CA |
| City | Marina del Rey |
| Address | 4503 Glencoe Avenue |
| ZIP | 90292 |
| Phone | 858-829-0829 |
| Website | https://www.armatapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 72 |
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Q&A For Armata Pharmaceuticals Stock
What is a current ARMP stock price?
Armata Pharmaceuticals ARMP stock price today per share is 1.28 USD.
How to purchase Armata Pharmaceuticals stock?
You can buy ARMP shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Armata Pharmaceuticals?
The stock symbol or ticker of Armata Pharmaceuticals is ARMP.
Which industry does the Armata Pharmaceuticals company belong to?
The Armata Pharmaceuticals industry is Biotechnology.
How many shares does Armata Pharmaceuticals have in circulation?
The max supply of Armata Pharmaceuticals shares is 36.18M.
What is Armata Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Armata Pharmaceuticals PE Ratio is now.
What was Armata Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Armata Pharmaceuticals EPS is -0.89 USD over the trailing 12 months.
Which sector does the Armata Pharmaceuticals company belong to?
The Armata Pharmaceuticals sector is Healthcare.